Ibuprofen Impurity 29 | CAS 106498-32-2 - Request Quote
Ibuprofen Impurity 29
| SZ CAT No: | SZ-I002079 |
| CAS No | 106498-32-2 |
| Mol.F. | C11H17N |
| Mol.Wt. | 163.3 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ibuprofen Impurity 29 is chemically (S)-3-Methyl-2-phenylbutan-1-amine. Ibuprofen Impurity 29 is supplied with detailed characterization data compliant with regulatory guideline. Ibuprofen Impurity 29 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ibuprofen.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 106498-32-2
Purchase 106498-32-2
Order 106498-32-2
Enquire 106498-32-2
price of 106498-32-2
106498-32-2 Supplier
106498-32-2 Manufacturer
106498-32-2 Exporter
buy high quality Ibuprofen Impurity 29
Purchase Ibuprofen Impurity 29
Ibuprofen Impurity 29 suppliers
Ibuprofen Impurity 29 manufacturers
Ibuprofen Impurity 29 price
Order Ibuprofen Impurity 29
Enquire Ibuprofen Impurity 29
Ibuprofen Impurity 29 cost
Ibuprofen Impurity 29 Supplier
Ibuprofen Impurity 29 Distributor
Ibuprofen Impurity 29 for Method Validation
Ibuprofen Reference Standard
Ibuprofen Impurity 29 for ANDA Filing
Ibuprofen Impurity 29 for Forced Degradation Studies
Ibuprofen Impurity 29 Identification Standards
Ibuprofen Impurity 29 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.